Peter Vis

Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug

Sarah McLeay, Peter Vis, Rolf P. G. van Heeswijk et al. · Antimicrobial Agents and Chemotherapy · 2014 · 75 citations · Full text

Pulmonary Tuberculosis, Pharmacokinetic Modeling, Healthy Subjects +15

Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents

Stéphane Blanche, Rosa Bologna, Pedro Cahn et al. · AIDS · 2009 · 51 citations

Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients

Thomas N. Kakuda, Janet R. Wade, Eric Snoeck et al. · Clinical Pharmacology & Therapeutics · 2010 · 50 citations

Population pharmacokinetic characterization of <scp>BAY</scp> 81‐8973, a full‐length recombinant factor <scp>VIII</scp>: lessons learned ‒ importance of including samples with factor <scp>VIII</scp> levels below the quantitation limit

Dirk Garmann, Sarah McLeay, Anita Shah et al. · Haemophilia · 2017 · 38 citations · Full text

Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1–Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial

Thomas N. Kakuda, Vanitha Sekar, Peter Vis et al. · AIDS Research and Treatment · 2012 · 30 citations · Full text